Dec 19 (Reuters) - Cyclopharm Ltd CYC.AX :
* FY18 REVENUE EXPECTED TO BE IN LINE WITH FY17
* CO RECONFIRMS IT WILL HAVE SUFFICIENT CASH TO COMPLETE USFDA SUBMISSION, FUND RESEARCH AND DEVELOPMENT AND NEAR TERM GROWTH INITIATIVES
Dec 19 (Reuters) - Cyclopharm Ltd CYC.AX :
* FY18 REVENUE EXPECTED TO BE IN LINE WITH FY17
* CO RECONFIRMS IT WILL HAVE SUFFICIENT CASH TO COMPLETE USFDA SUBMISSION, FUND RESEARCH AND DEVELOPMENT AND NEAR TERM GROWTH INITIATIVES